Modulation of wound healing and scar formation

Wound healing is a complex coordinated physiologic process involving various cytokines and growth factors that exert their influence through autocrine and paracrine pathways within the site of injury and repair. Cytokines and growth factors are polypeptide regulatory molecules that are secreted by different cell lines and are essential for normal wound healing for host defense. Conversely, they are also responsible for pathologic wound healing (abnormal scar formation and nonhealing). Modulators (eg, B-chain dimer platelet derived growth factor) are agents that influence the wound healing mechanism by creating a growth factor environment that allows optimal wound healing. The recent advances in genetic research have opened a new front in the management of chronic, nonhealing wounds. Gene therapy has a potential for localized and long-term expression of growth factors.

[1]  S. Bhanot,et al.  Current Applications of Platelet Gels in Facial Plastic Surgery , 2002, Facial plastic surgery : FPS.

[2]  R. Crystal,et al.  Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing. , 2002, Surgery.

[3]  O. Tepper,et al.  Gene therapy in plastic surgery. , 2002, Plastic and reconstructive surgery.

[4]  D. Bloom,et al.  Gene therapy, electroporation, and the future of wound-healing therapies. , 2002, Facial plastic surgery : FPS.

[5]  D. Hom,et al.  Growth factor therapy to improve soft tissue healing. , 2002, Facial plastic surgery : FPS.

[6]  D. Armstrong,et al.  The role of matrix metalloproteinases in wound healing. , 2002, Journal of the American Podiatric Medical Association.

[7]  D. Supp,et al.  Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. , 2002, The Journal of burn care & rehabilitation.

[8]  W. Eaglstein,et al.  Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. , 2001, Journal of the American Academy of Dermatology.

[9]  L C Parish,et al.  Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor‐2) to accelerate wound healing in venous ulcers , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  G. Borah,et al.  Cytokines, growth factors, and plastic surgery. , 2001, Plastic and reconstructive surgery.

[11]  M. Gondo,et al.  Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  K. C. Nowak,et al.  The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. , 2001, Archives of facial plastic surgery.